Valneva Aktie
2,02EUR | -0,11EUR | -4,99% |
WKN DE: A0MVJZ / ISIN: FR0004056851
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 83,62 |
Pfizer Inc. | 5,88 |
Bpifrance Participations SA /PRIVATE EQUITY/ | 5,32 |
Polar Capital LLP | 5,24 |
Polar Capital Funds Plc - Biotechnology Fund | 5,23 |
Deep Track Capital LP | 4,26 |
Groupe Grimaud La Corbière SA | 3,89 |
Government Pension Fund - Global (The) | 1,30 |
Vanguard Total International Stock Index Fund | 0,83 |
FCP Medical - BioHealth | 0,60 |
Vanguard Developed Markets Index Fund | 0,52 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 676 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,23 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 129 | 308 | 586 | 425 | 263 |
Summe Anlagevermögen | 145 | 151 | 240 | 208 | 207 |
Summe Aktiva | 274 | 460 | 826 | 633 | 469 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 85 | 105 | 115 | 152 | 209 |
Summe Fremdkapital | 139 | 382 | 655 | 413 | 341 |
Summe Eigenkapital | 135 | 77 | 171 | 220 | 128 |
Summe Passiva | 274 | 460 | 826 | 633 | 469 |
Adresse
Campus Bio-Ouest, 44800 Saint-Herblain | |
Telefon | +33 (2) 28-07-37-10 |
Internet | http://www.valneva.com |
Management
Anne-Marie Graffin
Independent Chairman |
Danièle Guyot-Caparros
Director |
Dipal Patel
Chief Commercial Officer |
Franck Charles Marie Grimaud
Chief Business Officer |
Hanneke Schuitemaker
Chief Scientific Officer |
James E. Connolly
Independent Director |
James R. Sulat
Vice Chairman |
Joshua Drumm
Vice President-Global Investor Relations |
Juan Carlos Jaramillo
Chief Medical Officer |
Kathrin U. Jansen
Director |
Kendra Wergin
Secretary & General Counsel |
Laetitia Bachelot-Fontaine
VP-Global Communications & European IR |
Maïlys Ferrère
Independent Director |
Peter Buhler
Chief Financial Officer |
Petra Pesendorfer
Chief People Officer |
Thomas Lingelbach
President, Chief Executive Officer & Director |
Vincent Dequenne
Chief Operating Officer |